{"transactions":[{"id":4624100,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":25446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":37500,"derivative":{"exercise_price":30.27,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":25446},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624099,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":10406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":18594,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":10406},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624098,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":62946,"derivative":{"exercise_price":30.27,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624097,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":29000,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624096,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":63346,"derivative":{"exercise_price":30.27,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624095,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":29400,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624094,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":35852,"price":43.0545,"value":1543589.934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624093,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":25446,"price":30.27,"value":770250.42,"ownership":{"direct":true},"balance_after":48967,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624092,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":10406,"price":30.69,"value":319360.14,"ownership":{"direct":true},"balance_after":23521,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624091,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"sale","planned":false,"acquired":false,"shares":800,"price":43,"value":34400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624090,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":400,"price":30.27,"value":12108.0,"ownership":{"direct":true},"balance_after":13915,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624089,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":400,"price":30.69,"value":12276.0,"ownership":{"direct":true},"balance_after":13515,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624088,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1800,"price":43.0146,"value":77426.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624087,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":true,"shares":900,"price":30.27,"value":27243.0,"ownership":{"direct":true},"balance_after":14915,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624086,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":true,"shares":900,"price":30.69,"value":27621.0,"ownership":{"direct":true},"balance_after":14015,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4613574,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":10754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":64246,"derivative":{"exercise_price":30.27,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":10754},"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613573,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date"}],"balance_after":30300,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613572,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":22954,"price":43.1014,"value":989349.5356,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613571,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":10754,"price":30.27,"value":325523.58,"ownership":{"direct":true},"balance_after":36069,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613570,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":12200,"price":30.69,"value":374418.0,"ownership":{"direct":true},"balance_after":25315,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613569,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":42.7947,"value":42794.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613568,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":4500,"price":42.2475,"value":190113.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.59 to $42.57. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14115,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613567,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":5500,"price":41.9839,"value":230911.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.51 to $42.32. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18615,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":775375,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-05-18T16:14:12.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0002009762-26-000004","document":"form4-05182026_080508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000004/form4-05182026_080508.xml","form_type":"4"}},{"id":775374,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-18T16:14:12.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8882,"price":31.83,"value":282714.06,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":24115,"source":{"system":"sec-edgar","filing":"0002009762-26-000004","document":"form4-05182026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000004/form4-05182026_080508.xml","form_type":"4"}},{"id":775373,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-18T16:14:12.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing."}],"balance_after":32997,"source":{"system":"sec-edgar","filing":"0002009762-26-000004","document":"form4-05182026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000004/form4-05182026_080508.xml","form_type":"4"}},{"id":931280,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":false,"shares":2662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":7988,"derivative":{"underlying":"Common Stock","underlying_shares":2662},"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931279,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":2188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":4175,"derivative":{"underlying":"Common Stock","underlying_shares":2188},"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931278,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":12200,"derivative":{"underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931277,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":42600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":42600,"derivative":{"exercise_price":36.76,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":42600},"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931276,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1372,"price":36.82,"value":50517.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1290,"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931275,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":true,"shares":2662,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2662,"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931274,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1153,"price":36.82,"value":42453.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1035,"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931273,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":2188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2188,"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":1153960,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-05-09T16:07:59.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001415889-25-012477","document":"form4-05092025_080555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925012477/form4-05092025_080555.xml","form_type":"4"}},{"id":1153959,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-09T16:07:59.000Z","date":"2025-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8869,"price":29.86,"value":264828.34,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":9881,"source":{"system":"sec-edgar","filing":"0001415889-25-012477","document":"form4-05092025_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925012477/form4-05092025_080555.xml","form_type":"4"}},{"id":1153958,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-09T16:07:59.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18750,"source":{"system":"sec-edgar","filing":"0001415889-25-012477","document":"form4-05092025_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925012477/form4-05092025_080555.xml","form_type":"4"}},{"id":1293265,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T16:10:18.000Z","date":"2025-01-25","kind":"grant","planned":false,"acquired":true,"shares":10650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":10650,"derivative":{"underlying":"Common Stock","underlying_shares":10650},"source":{"system":"sec-edgar","filing":"0001415889-25-002161","document":"form4-01282025_090114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925002161/form4-01282025_090114.xml","form_type":"4"}},{"id":1293264,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2025-01-28T16:10:18.000Z","date":"2025-01-25","kind":"grant","planned":false,"acquired":true,"shares":37400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":37400,"derivative":{"exercise_price":38.01,"expiration_date":"2035-01-25","underlying":"Common Stock","underlying_shares":37400},"source":{"system":"sec-edgar","filing":"0001415889-25-002161","document":"form4-01282025_090114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925002161/form4-01282025_090114.xml","form_type":"4"}},{"id":1293263,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T16:10:18.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":false,"shares":2187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":6563,"derivative":{"underlying":"Common Stock","underlying_shares":2187},"source":{"system":"sec-edgar","filing":"0001415889-25-002161","document":"form4-01282025_090114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925002161/form4-01282025_090114.xml","form_type":"4"}},{"id":1293262,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T16:10:18.000Z","date":"2025-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1151,"price":38.01,"value":43749.51,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1036,"source":{"system":"sec-edgar","filing":"0001415889-25-002161","document":"form4-01282025_090114.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925002161/form4-01282025_090114.xml","form_type":"4"}},{"id":1293261,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T16:10:18.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":true,"shares":2187,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2187,"source":{"system":"sec-edgar","filing":"0001415889-25-002161","document":"form4-01282025_090114.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925002161/form4-01282025_090114.xml","form_type":"4"}},{"id":1528753,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T08:05:07.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-012110","document":"form4-05032024_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588924012110/form4-05032024_080501.xml","form_type":"4"}},{"id":1528752,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2024-05-03T08:05:07.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":75000,"derivative":{"exercise_price":30.27,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-012110","document":"form4-05032024_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588924012110/form4-05032024_080501.xml","form_type":"4"}},{"id":1669851,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-01-26T16:59:58.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":8750,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001415889-24-001875","document":"form4-01262024_090148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588924001875/form4-01262024_090148.xml","form_type":"4"}},{"id":1669850,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2024-01-26T16:59:58.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":42500,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001415889-24-001875","document":"form4-01262024_090148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588924001875/form4-01262024_090148.xml","form_type":"4"}}]}